Intravenous stem cells therapy - good for heart attack patients

A new research has concluded that Heart attack patients that had received a new intravenous adult stem cell therapy which is known as Provacel, had a lower number of negative cases such as that of cardiac arrhythmias, and had significant visible and outstanding improvements in heart, lung and global function compared to those who underwent the procedure of placebo.

What is Provacel?
Provacel is a preparation of adult stem cells pre-formulated for intravenous delivery by the drugs manufacture, Osiris Therapeutics.

A unique benefit of stem cell product is that it is given to patients through a standard IV line.

The cells have an inherent capability to expand and multiply under controlled conditions, and the expanded cells have the ability to develop into different kinds of cells in the appropriate environment.